Ms. Hao Li – Tumor Immunology – Young Scientist Award

Ms. Hao Li - Tumor Immunology - Young Scientist Award

First Hospital of China Medical University - China

Author Profile

Scopus

EARLY ACADEMIC PURSUITS

Li Hao began his academic journey at Dalian Medical University in September 2015, majoring in Immunology, Biochemistry, Surgery, and Internal Medicine. During this period from 2015 to 2020, he laid the foundational knowledge in the medical sciences that would serve as the basis for his future specialization. His undergraduate studies provided him with a comprehensive understanding of the human body's immune system, biochemistry, surgical techniques, and internal medicine.Li Hao pursued his Master's degree in Emergency Medicine and Molecular Biology at China Medical University. This advanced academic pursuit enabled him to delve deeper into specialized areas of medicine, focusing on emergency care and the molecular mechanisms underlying various medical conditions.

PROFESSIONAL ENDEAVORS

In May 2021, Li Hao started his professional career as a Resident Physician at the First Hospital of China Medical University. During his tenure from May 2021 to August 2021, he gained hands-on experience in clinical settings, honing his skills in medical records writing and cardiopulmonary resuscitation (CPR). This role allowed him to apply his theoretical knowledge from his undergraduate studies in a practical setting, preparing him for more specialized roles in the medical field.In June 2023, Li Hao transitioned to the role of an Assistant at the First Hospital of China Medical University, where he continues to work to the present day. As an Assistant, he has been involved in research projects and clinical work, further expanding his expertise and contributing to advancements in the medical field.

CONTRIBUTIONS AND RESEARCH FOCUS ON TUMOR IMMUNOLOGY

Li Hao's research interests are diverse and interdisciplinary, focusing on the areas of nanomaterials, hepatocellular carcinoma, and macrophage biology. His research aims to explore innovative approaches and treatments for these medical conditions, leveraging the latest advancements in molecular biology and emergency medicine.

IMPACT AND INFLUENCE

Li Hao's contributions to the medical field extend beyond his professional roles, as he actively engages in research and academic pursuits that have the potential to make a significant impact. His research in nanomaterials, hepatocellular carcinoma, and macrophage biology could lead to breakthroughs in treatment options and improve patient outcomes in these areas.

ACADEMIC SITES

Li Hao's academic achievements and research contributions have likely been cited in various scientific publications and conferences. His interdisciplinary research in nanomaterials, hepatocellular carcinoma, and macrophage biology demonstrates his commitment to advancing medical science and contributing valuable insights to the academic community.

LEGACY AND FUTURE CONTRIBUTIONS

As Li Hao continues to pursue his career in emergency medicine and molecular biology, his interdisciplinary research and clinical experience will undoubtedly leave a lasting legacy in the medical field. His dedication to improving patient care and advancing medical science positions him as a promising young professional with the potential to make significant contributions to the future of healthcare.

NOTABLE PUBLICATIONS

Nanomaterials modulate tumor-associated macrophages for the treatment of digestive system tumors.Ā  2024

Glutamate Chemical Exchange Saturation Transfer (GluCEST) MRI to Evaluate the Rapid Antidepressant Effects of Ketamine in the Hippocampus of Rat Depression Model. 2024 (1)

Preclinical multi-physiologic monitoring of immediate-early responses to diverse treatment strategies in breast cancer by optoacoustic imaging. 2024

Glutamate alterations in the premature infant brain during different gestational ages with glutamate chemical exchange saturation transfer imaging: a pilot study. 2023 (1)

Xenon inhalation attenuates neuronal injury and prevents epilepsy in febrile seizure Sprague-Dawley pups. 2023 (1)

 

Prof Dr. Qiao Li – Tumor Immunology – Best Researcher Award

Prof Dr. Qiao Li - Tumor Immunology - Best Researcher Award

University of Michigan - United States

AUTHOR PROFILE

Scopus

EARLY ACADEMIC PURSUITS

Qiao Li, Ph.D., embarked on her academic journey with a Bachelor's degree in Microbiology from Wuhan University, Wuhan, P.R. China, in 1982. Continuing her pursuit of knowledge, she obtained a Master's degree in Environmental Biology from the Institute of Hydrobiology, Chinese Academy of Sciences, Wuhan, P.R. China, in 1985. These early academic pursuits laid the foundation for her comprehensive training in the biological sciences.

PROFESSIONAL ENDEAVORS

In 1994, Qiao Li achieved a Ph.D. in Biological Sciences from Wayne State University, Detroit, Michigan, USA. Subsequently, she assumed the role of Research Professor of Tumor Immunology and Immunotherapy at the University of Michigan Medical School, Ann Arbor, Michigan, USA. Her professional endeavors showcase a commitment to advancing the understanding and treatment of cancer through immunological approaches.

CONTRIBUTIONS AND RESEARCH FOCUS ON TUMOR IMMUNOLOGY

Qiao Li's contributions extend beyond her role as a Research Professor. As a Section Editor or Editorial Board Member for the International Journal of Biological Sciences, she actively contributes to the dissemination of scientific knowledge. Her research focus lies in Tumor Immunology and Cancer Immunotherapy, where she explores innovative strategies to harness the immune system for effective cancer treatment.

IMPACT AND INFLUENCE

Qiao Li's impact is evident in her multifaceted role, including positions such as Section Editor and Editorial Board Member. Her influence extends to teaching, research mentorship, and overseeing graduate student committees at the University of Michigan. As a Research Professor, she contributes significantly to the advancement of tumor immunology, leaving a lasting imprint on the academic and research community.

ACADEMIC CITES

Qiao Li's involvement as a Section Editor and Editorial Board Member suggests that her work likely receives recognition within the academic community. Her contributions to the International Journal of Biological Sciences and other scholarly activities contribute to the dissemination and acknowledgment of her expertise in the field.

LEGACY AND FUTURE CONTRIBUTIONS HIGHLIGHT

Qiao Li's legacy is built upon her extensive involvement in education, research mentorship, and editorial roles. Her commitment to supervising undergraduate and graduate students, along with her contribution to medical student educational activities, underscores her dedication to fostering the next generation of scientists. Looking ahead, Qiao Li is poised to continue making significant contributions to tumor immunology and cancer immunotherapy, leaving a lasting legacy through her ongoing research, mentorship, and editorial responsibilities. Her role in training international Ph.D. students further signifies a global impact in the field of cancer research.

NOTABLE PUBLICATIONS

Cancer stem cell antigen nanodisc cocktail elicits anti-tumor immune responses in melanoma. 2022

Efficacy of an ALDH peptide-based dendritic cell vaccine targeting cancer stem cells. 2022

Emerging concepts regarding pro- and anti tumor properties of B cells in tumor immunity. 2022

CPNE8 Promotes Gastric Cancer Metastasis by Modulating Focal Adhesion Pathway and Tumor Microenvironment. 2022

Targeting cancer stem cells via integrin Ī²4. 2022